In the head-to-head comparison between tirzepatide and semaglutide, the two drugs yielded similar risks for component endpoints all-cause mortality (HR 1.03, 95% CI 0.84 to 1.27), myocardial infarction (HR 1.03, 95% CI 0.88 to 1.21) and stroke (HR 1.15, 95% CI 0.92 to 1.45) (Fig
Nonetheless, this study demonstrated that liraglutide did not significantly change PASI and DLQI in these patients when compared with placebo
pmid:29472646 12
The more fat a man carries, the more of his own testosterone gets siphoned off and the lower his measured levels read
Most quality-discipline guidance in the field focuses on the COA and rightly so, since the COA is the authoritative document but the vial label is the physical checkpoint, the thing in your hand at the bench
Ongoing accountability is built into every visit